Login or sign up
For business

Limula Biotech

4.0Β· 12 reviews
Average ratingGreat
4.0/ 5

Based on 12 reviews

533%
433%
333%
20%
10%
Ask AI

Ask Trustburn about Limula Biotech

Based on 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Dmitriy Peregudov
Reviews 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce interdum finibus est at placerat. Quisque venenatis nisi sed erat dignissim, eget elementum purus sagittis. Nullam pellentesque scelerisque risus, vel sagittis enim molestie ac. Maecenas sed nisl in risus imperdiet lobortis. Nulla vel vulputate velit. Ut venenatis venenatis scelerisque. Nulla facilisi. Integer nec sapien vitae risus rutrum rhoncus eu vitae nisl.

Michele Siggelkow
Reviews 1

The services provided by Limula Biotech are simply outstanding! Their commitment to quality and customer satisfaction sets them apart from others in the industry. I am extremely happy with the results and would definitely choose them again in the future. βœ¨πŸ‘

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Limula Biotech

Limula Biotech proposes an automated gene therapy manufacturing platform that operates at the patient bedside.

This platform allows to automatically manufacture, from a patient white blood cell sample, genetically engineered cells at its bedside. Limula Biotech is building the first fully contained automated system for CGT manufacturing, allowing rapid and safe production of treatments directly at the patients beside. By enabling distributed manufacturing at the hospital, Limula’s technology will save time, cut costs, simplify logistics, and ultimately increase the safety and accessibility of these cutting edge personalized treatments.

Founded in 2018, Limula Biotech envision to bring ex vivo gene-engineered cell therapies to the people.